What Pharma Sponsors Actually Look at on a CRO’s Website Before Sending an RFI

Pharma sponsors usually start by looking at your website when evaluating CROs. Even before reaching out or requesting information, they form opinions based on what they see online. Your website is like a first interview, and many CROs don’t realize how much this moment can influence whether a sponsor will request an RFI.

Does Your Website Signal the Right Therapeutic Expertise?

Sponsors start by checking if your CRO has proven experience in their specific therapeutic area. They want more than a general overview. They look for a clear track record in fields like oncology, rare disease, CNS, or cardiology.

Sponsors notice vague claims right away. If you say “broad therapeutic expertise” without giving details, it raises concerns. They want to see specific trial types, regulatory history, and team credentials.

“Pharma sponsors are essentially reading your website the same way they’d read a vendor qualification packet. If your therapeutic area pages read like marketing copy rather than a clinical record, you’ve already lost credibility before the conversation starts. Specificity is the currency that earns the next step.” — Strategy Team, Emulent Marketing.

What to include on therapeutic area pages so sponsors take you seriously:

• Named disease areas and indications: List the exact conditions your CRO has worked with, not just broad terms like “oncology” or “neuroscience.” Sponsors search by specific indication, so general categories don’t meet their needs.
• Phase experience by area: Clearly state if your team has managed Phase I, II, III, or IV trials in each therapeutic area. Sponsors often look for experience with the exact phase they plan to run.
• Regulatory submission history: Include any IND filings, NDA support, or FDA interactions relevant to each therapeutic area. This shows your team has worked within regulated development, not just research.
• Key team credentials tied to the area: Short bios or highlights showing your team’s direct clinical or scientific experience in each area are much more valuable than general descriptions.

How Do Sponsors Read Your Regulatory and Compliance Section?

Sponsors understand that your CRO’s compliance and audit history can impact their own risk. They look for evidence on your website that your quality management is solid and proven.

Don’t just say you are “GCP-compliant.” Sponsors want to see that quality is part of your operations. How you present compliance shows how seriously your team takes it.

What compliance-focused sponsors look for on your site:

• GCP and ICH references by name: Explicitly name the standards your operations follow. Sponsors check whether you reference GCP, ICH E6(R2), and applicable FDA and EMA guidance. Generic compliance language that doesn’t name standards reads as surface-level.
• Quality management system signals: Even if you don’t share full SOPs, saying you have a documented quality management system with clear responsibility shows sponsors your team has real infrastructure, not just good intentions.
• Audit and inspection history language: Mentioning FDA inspections, audit results, or CAPA processes shows your team has been reviewed by outside experts and passed. This quickly builds trust.
• Regulatory submission support specifics: Clearly state if your team has supported IND, BLA, NDA, or MAA submissions, and in which regions. Sponsors want to know if your regulatory team has real agency review experience.

“We see CRO websites every week that bury their compliance story or skip it entirely. Sponsors aren’t just buying execution capacity; they are buying risk management. If your website doesn’t show that you understand the regulatory stakes, you won’t make the short list.” — Strategy Team, Emulent Marketing.

What Does Your Leadership and Team Page Actually Communicate?

Sponsors are not just buying services. They are starting a long-term relationship with a team that will handle execution, regulatory review, and ongoing decisions. Your team page is essential.

A basic “Our Team” page with just headshots and short titles is not enough for sponsors. They want to see real scientific and operational depth. They look for PhDs, MDs, and regulatory experts with experience at pharma companies, the FDA, or academic centers. They also check for team stability, since high turnover is a risk they want to avoid.

What team pages need to show to pass the pre-RFI review:

• Relevant credentials front and center: Advanced degrees, pharma or regulatory experience, and special training are important to sponsors. Don’t hide this information in a long paragraph.
• Connect team bios to therapeutic areas: Sponsors should be able to find the right experts for their program without reading every profile.
• Leadership stability indicators: Long tenures and career histories that show continuity communicate that your CRO won’t lose institutional knowledge mid-trial. Sponsors have experienced handoffs that disrupted their programs, and they look for signals that this won’t happen again.
• Named project leadership roles and scope: If your team leads have been principal CRA, project director, or regulatory lead on major programs, sharing that builds confidence. Even if you can’t name the sponsor or trial, describing the scope and complexity is helpful.

Do Your Service Pages Show Operational Depth or Surface-Level Summaries?

Many CRO websites only list services in broad terms like clinical trial management, data management, and regulatory affairs. For sponsors doing serious pre-RFI research, this is not enough. They want to see the depth and infrastructure behind each service.

Sponsors planning global trials want to see details about your site networks, recruitment, EDC platforms, and biostatistics. If your website lacks these details, they will move on. CROs often lose RFIs by not describing their services clearly enough.

What service pages should communicate to serious sponsors:

• Site network specifics: Mention the number of investigator sites you work with, the regions they cover, and whether you have preferred site relationships in key geographies. “Extensive site network” without numbers or regions means nothing to a sponsor trying to match your reach to their enrollment geography.
• Describe your enrollment approach, including any digital tools, registries, or diversity strategies you use. Sponsors are very concerned about enrollment risk.
• Name the EDC or tech systems you use, such as Medidata Rave or Veeva Vault. Sponsors have platform preferences and expect you to be clear about this.
• Sponsors want to know if biostatistics and data management are in-house or outsourced, and your experience with adaptive designs and complex stats.

“CRO service pages often read like a menu without prices or ingredients. A sponsor comparing three vendors is trying to figure out what is actually inside each offering. The more operational detail you put on the page, the less work they have to do to imagine your team running their trial.” — Strategy Team, Emulent Marketing

How Does Your Website Handle Global Reach and Specialty Capabilities?

Sponsors look for CRO partners with proven capacity in regions like the US, EU, Asia-Pacific, and Latin America. If your site does not show international reach, you may be filtered out. Make your regional presence clear.

Sponsors also look for specialty capabilities that fit their program’s complexity. For example, if they are running a rare disease trial with a decentralized component, they want to see that your site shows experience with decentralized clinical trials, wearables, or remote monitoring. These are now qualifying criteria for many trials, not just niche skills.

What global and specialty sections should be addressed to pass sponsor review:

• Capabilities: Show your global capabilities by listing the countries or regions where you operate and stating if you have local offices, in-country regulatory staff, or partnerships with local CROs. Don’t just claim global reach—back it up. Update your site so sponsors see your real global presence and specialty expertise. Make these strengths clear to turn more sponsor visits into real opportunities.
• Decentralized trial experience with process detail: If you run decentralized clinical trials, explain your process, such as how you manage remote consent, coordinate home health nurses, and keep data integrity across different sites. Describing your process shows operational maturity better than taglines.
• Rare disease and orphan drug pathway knowledge: Sponsors in rare disease seek specific experience with small patient populations, natural history studies, and the FDA’s orphan drug pathway. This is a specialized area where generic clinical trial experience is not a substitute.
• Pediatric and special populations experience: Any documented work in pediatric trials, elderly populations, or complex patient subgroups signals capability that many CROs either lack or fail to show. Sponsors searching this space will notice it quickly if you have it and show it.

What Do Sponsors Conclude When They Can’t Find What They’re Looking For?

This question is just as important as the others. If a sponsor visits your website and can’t find your therapeutic area focus, site network size, technology platforms, or a named scientific leader, they will make a judgment. That judgment will likely work against you.

Sponsors see your website as your best case. If they find it vague, generic, or hard to use, they take that as a sign of what working with your team might be like. If basic clinical information is hard to find, they may think other things will be, too. This impression can cost you the RFI before you ever speak to them.

Common website gaps that cost CROs RFI submissions:

• No clear service-to-indication mapping: If sponsors can’t connect your capabilities to their therapeutic area without searching through many pages, they will stop looking. Make the link between your services and your experience easy to find.
• Missing technology platform references: Not naming the EDC, CTMS, or eCOA platforms your team uses makes sponsors question whether your data practices are up to date. Technology is now a qualifying criterion, not a bonus.
• Generic team pages without clinical context: Listing names and titles without credentials, program scope, or therapeutic focus does not set your team apart. Sponsors want to see real people, not just an org chart.
• No clear path to a relevant contact: If sponsors can’t easily find a way to reach a scientific or business development contact with the right expertise, they often move on instead of searching for a form. A generic contact page sends the wrong message to sponsors who want to speak with someone who understands their area.

“Most CROs think about their website as a branding tool. Sponsors think about it as a qualification checklist. When you close those two perspectives together, your website becomes a real business development asset rather than a digital brochure.” — Strategy Team, Emulent Marketing.

What This Means for Your CRO’s Digital Presence

Pharma sponsors doing pre-RFI research are not casual visitors. They are experienced evaluators who know what a strong CRO looks like, and they use your website to decide if you are worth a full proposal. Closing the gap between what they need and what your site shows is one of the best investments a CRO marketing team can make.

Getting your website right means speaking the clinical and regulatory language sponsors use, showing the depth behind each service area, and making it straightforward for the right person to find the right information fast. That combination turns website visits into RFI submissions.

At Emulent, we work with CROs and life sciences organizations to build websites and content strategies that convert sponsor interest into real RFI submissions. We understand the clinical and regulatory language that builds credibility with pharma evaluators, and we know how to structure content that answers the questions sponsors are actually asking. If you want your site to work harder for your business development team, contact the Emulent team to talk about your CRO marketing strategy.